Relation of protease inhibitor phenotypes to obstructive lung diseases in a community.

Alpha-1-antitrypsin (protease inhibitor) phenotypes and longevity.

[Gender-Specific Differences in Obstructive Lung Diseases].

Terminology in chronic obstructive lung diseases.

Tucson epidemiologic study of obstructive lung diseases. II: Effects of in-migration factors on the prevalence of obstructive lung diseases.

A new method for the determination of alpha1-protease inhibitor (alpha1-antitrypsin) phenotypes based on the formation of alpha1-protease inhibitor allele product-elastase complexes.

Clinical value of rebreathing test in obstructive lung diseases.

Occupational exposures in relation to symptomatology and lung function in a community population.

Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Secretory leukocyte protease inhibitor modulates urethane-induced lung carcinogenesis.

Computational modeling of the obstructive lung diseases asthma and COPD.

Obstructive adenoids in relation to otitis media.

Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease.

Alpha1-antitrypsin phenotypes and lung function in a moderately polluted northern Ontario community.

A bumblebee (Bombus ignitus) venom serine protease inhibitor that acts as a microbial serine protease inhibitor.

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens.

Biochemical basis of prolidase deficiency. Polypeptide and RNA phenotypes and the relation to clinical phenotypes.

A protease inhibitor isolated from Planomonospora parontospora.

A cohort study of mortality in relation to lung function.

Lung ultrasound in community-acquired pneumonia and in interstitial lung diseases.

Mast cells, their subtypes, and relation to asthma phenotypes.

Role of Protease-Inhibitors in Ocular Diseases.

Molecular mechanics analysis of inhibitor binding to HIV-1 protease.

[Lobar emphysema. Important differential diagnosis of obstructive lung diseases in childhood].

Phenotypes and disease characterization in chronic obstructive pulmonary disease. Toward the extinction of phenotypes?

Suggest Documents

Alpha-1-antitrypsin (protease inhibitor) phenotypes and longevity.

[Gender-Specific Differences in Obstructive Lung Diseases].

Terminology in chronic obstructive lung diseases.

Tucson epidemiologic study of obstructive lung diseases. II: Effects of in-migration factors on the prevalence of obstructive lung diseases.

A new method for the determination of alpha1-protease inhibitor (alpha1-antitrypsin) phenotypes based on the formation of alpha1-protease inhibitor allele product-elastase complexes.

Clinical value of rebreathing test in obstructive lung diseases.

Occupational exposures in relation to symptomatology and lung function in a community population.

Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Secretory leukocyte protease inhibitor modulates urethane-induced lung carcinogenesis.

Computational modeling of the obstructive lung diseases asthma and COPD.

Obstructive adenoids in relation to otitis media.

Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease.

Alpha1-antitrypsin phenotypes and lung function in a moderately polluted northern Ontario community.

A bumblebee (Bombus ignitus) venom serine protease inhibitor that acts as a microbial serine protease inhibitor.

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens.

Biochemical basis of prolidase deficiency. Polypeptide and RNA phenotypes and the relation to clinical phenotypes.

A protease inhibitor isolated from Planomonospora parontospora.

A cohort study of mortality in relation to lung function.

Lung ultrasound in community-acquired pneumonia and in interstitial lung diseases.

Mast cells, their subtypes, and relation to asthma phenotypes.

Role of Protease-Inhibitors in Ocular Diseases.

Molecular mechanics analysis of inhibitor binding to HIV-1 protease.

[Lobar emphysema. Important differential diagnosis of obstructive lung diseases in childhood].

Phenotypes and disease characterization in chronic obstructive pulmonary disease. Toward the extinction of phenotypes?

Relation of protease inhibitor phenotypes to obstructive lung diseases in a community.

Recommend Documents

Follow Us